In conversation with... Shahida Din and Beatriz Gros episode artwork

EPISODE · Nov 1, 2024 · 34 MIN

In conversation with... Shahida Din and Beatriz Gros

from Listen to The Lancet Gastroenterology & Hepatology · host The Lancet

Shahida Din (Western General Hospital, Edinburgh) and Beatriz Gros (Reina Sofía University Hospital, Cordoba) discuss two new papers on the harms associated with receiving placebo in induction and maintenance trials of biological therapies and small molecules in inflammatory bowel disease.

NOW PLAYING

In conversation with... Shahida Din and Beatriz Gros

0:00 34:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Listen to The Lancet Gastroenterology & Hepatology?

This episode is 34 minutes long.

When was this Listen to The Lancet Gastroenterology & Hepatology episode published?

This episode was published on November 1, 2024.

What is this episode about?

Shahida Din (Western General Hospital, Edinburgh) and Beatriz Gros (Reina Sofía University Hospital, Cordoba) discuss two new papers on the harms associated with receiving placebo in induction and maintenance trials of biological therapies and small...

Can I download this Listen to The Lancet Gastroenterology & Hepatology episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!